Cancer

Causing the death of cancer cells while leaving healthy ones in tact is central to the goal of safer, more effective forms of treatment for the disease, and scientists have now come up with one that leans heavily a common household item – salt.

Scientists at Harvard University have developed a new type of cancer vaccine that was combined with chemotherapy to prove highly effective in mice, eliminating the cancer cells and stopping them from coming back for some time after.

Radiation therapy is currently our best shot at treating cancer, but healthy cells often become unfortunate collateral damage. New research shows how the treatment can be made safer by reducing the time involved from weeks to seconds.

A new type of copper-based nanoparticle has shown effectiveness in killing off tumor cells in mice. But by combining it with immunotherapy scientists say it produced long-lasting effects, quickly killing off any cancer cells that dared to return.

A newly published report from the American Cancer Society has shone a light on increases in cancer survival rates over the past few decades, with the period examined also including the largest one-year decline ever recorded.

Particle accelerators could be incredibly useful for medicine – if they weren’t so huge. Now, scientists at Stanford have managed to shrink the tech down to fit on a computer chip, which could lead to more precise cancer radiation therapies.

A new AI system is proving more effective at detecting breast cancer in mammograms than trained radiologists. The software, developed by researchers from Google, is not designed to replace humans but instead improve current diagnostic processes.

Australian researchers have affirmed an unusual, almost paradoxical, observation that cancer patients with high body mass index tend to display greater survival rates than patients with average healthy weights.

A promising new cancer drug will soon enter phase 2 clinical trials, after finding success in animal models and preliminary human studies. Known as AMG 510, the drug targets a gene mutation that’s one of the most common causes of cancer.

New research, led by scientists from the University of Rochester, has homed in on a mechanism responsible for causing the cognitive impairment seen in patients who receive cranial radiotherapy for brain cancer.

Scientists at the Salk Institute have been researching some of the cellular processes triggered by chemotherapy treatments, uncovering a mechanism that could lead to new and improved treatments that prevent mitochondria hindering their effectiveness.

Some bacteria use tiny syringes to inject toxins into their host’s cells. Now, researchers from the Max Planck Institute have found a way to use this to our advantage, by swapping out these toxins for other chemicals, like drugs.